SAN DIEGO--(BUSINESS WIRE)--Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today announced the launch of the “100 Million Cell Challenge,” a global ...

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today ...

Quantum Genomics releases its 2022 financial results and provides an update on its M&A discussions Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC) today announces its results for the full ...

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces its participation in the upcoming Festival ...

Today, the National Quantum Computing Centre (NQCC) launched its first Insights Paper, "The convergence of healthcare and pharmaceuticals with quantum computing: A new fronter in medicine", exploring ...

* AT END OF THIS TRIAL - RESULTS OF WHICH ARE EXPECTED IN FIRST HALF OF 2019 - A PHASE III CLINICAL TRIAL COULD THEN BE INITIATED WITH QGC001. SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: European ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 12.2% of Compugen shares are owned by institutional investors. 9.5% of Compugen ...

* QUANTUM GENOMICS SECURED NEW FINANCING, PUBLISHED ITS FINANCIAL STATEMENTS FOR FISCAL YEAR 2019 AND PROVIDES 2019 HIGHLIGHTS * DESPITE CURRENT PUBLIC HEALTH CRISIS AND ANY FINANCIAL CONSEQUENCES IT ...

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (QSI) (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ...

Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, announces its ...